Optimal use of ATG in GVHD prophylaxis in allogeneic HSCT

Conference Papers Year : 2018

(1, 2)

1
2

Marie-Thérèse Rubio

Connectez-vous pour contacter l'auteur

Service d'Hématologie [CHRU Nancy]

Life Sciences [q-bio] Immunotherapy

https://hal.univ-lorraine.fr/hal-03636001

Submitted on : Friday, April 8, 2022-8:57:14 PM

Last modification on : Tuesday, June 25, 2024-11:27:36 AM

hal-03636001 , version 1 (08-04-2022)

Marie-Thérèse Rubio. Optimal use of ATG in GVHD prophylaxis in allogeneic HSCT. Chinese BMT congress, Jun 2018, Beijing, China. ⟨hal-03636001⟩